CDXS Codexis Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CDXS

Price (delayed)

$22.67

Market cap

$1.46B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.41

Enterprise value

$1.34B

Highlights
CDXS's quick ratio is up by 47% year-on-year and by 3.8% since the previous quarter
The debt has contracted by 7% YoY and by 2.5% from the previous quarter
The equity has surged by 65% year-on-year but it has declined by 3.7% since the previous quarter
The company's net income has shrunk by 76% YoY and by 6% QoQ
The EPS has dropped by 64% year-on-year and by 2.5% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://www.cedexis.com/
Peers: BCPC DD MRK PFE

Key stats

What are the main financial stats of CDXS
Market
Shares outstanding
64.49M
Market cap
$1.46B
Enterprise value
$1.34B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
8.92
Price to sales (P/S)
20.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.57
Earnings
Revenue
$72.42M
EBIT
-$25.09M
EBITDA
-$20.36M
Free cash flow
-$27M
Per share
EPS
-$0.41
Free cash flow per share
-$0.42
Book value per share
$2.54
Revenue per share
$1.13
TBVPS
$3.25
Balance sheet
Total assets
$212.17M
Total liabilities
$48.43M
Debt
$24.32M
Equity
$163.74M
Working capital
$151.01M
Liquidity
Debt to equity
0.15
Current ratio
7.7
Quick ratio
7.34
Net debt/EBITDA
5.77
Margins
EBITDA margin
-28.1%
Gross margin
78.7%
Net margin
-35.1%
Operating margin
-34.9%
Efficiency
Return on assets
-14.3%
Return on equity
-19.6%
Return on invested capital
-37%
Return on capital employed
-13.2%
Return on sales
-34.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDXS stock price

How has the Codexis stock price performed over time
Intraday
4.95%
1 week
6.28%
1 month
2.58%
1 year
76.15%
YTD
3.85%
QTD
0.04%

Financial performance

How have Codexis's revenue and profit performed over time
Revenue
$72.42M
Gross profit
$57M
Operating income
-$25.25M
Net income
-$25.43M
Gross margin
78.7%
Net margin
-35.1%
The company's net income has shrunk by 76% YoY and by 6% QoQ
The company's operating income has shrunk by 67% YoY and by 6% QoQ
The net margin has plunged by 64% YoY
The operating margin has dropped by 56% year-on-year

Growth

What is Codexis's growth rate over time

Valuation

What is Codexis stock price valuation
P/E
N/A
P/B
8.92
P/S
20.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.57
The EPS has dropped by 64% year-on-year and by 2.5% since the previous quarter
The equity has surged by 65% year-on-year but it has declined by 3.7% since the previous quarter
CDXS's price to book (P/B) is 34% lower than its 5-year quarterly average of 12.8 but 9% higher than its last 4 quarters average of 7.8
The price to sales (P/S) is 71% higher than the 5-year quarterly average of 11.2 and 30% higher than the last 4 quarters average of 14.8
CDXS's revenue is up by 7% year-on-year and by 4.9% since the previous quarter

Efficiency

How efficient is Codexis business performance
The return on sales has dropped by 62% year-on-year
The company's return on invested capital has shrunk by 56% YoY and by 3.1% QoQ
Codexis's return on assets has decreased by 46% YoY but it has increased by 3.4% QoQ
Codexis's return on equity has decreased by 38% YoY but it has increased by 7% QoQ

Dividends

What is CDXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDXS.

Financial health

How did Codexis financials performed over time
Codexis's current ratio has increased by 50% YoY and by 4.3% QoQ
CDXS's quick ratio is up by 47% year-on-year and by 3.8% since the previous quarter
The debt is 85% less than the equity
The equity has surged by 65% year-on-year but it has declined by 3.7% since the previous quarter
The company's debt to equity fell by 42% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.